Rasmussen John C, Aldrich Melissa B, Tan I-Chih, Darne Chinmay, Zhu Banghe, O'Donnell Thomas F, Fife Caroline E, Sevick-Muraca Eva M
Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Tex.
Division of Vascular Surgery, Tufts Medical Center, Boston, Mass.
J Vasc Surg Venous Lymphat Disord. 2016 Jan;4(1):9-17. doi: 10.1016/j.jvsv.2015.06.001. Epub 2015 Jul 16.
Recent advancements in near-infrared fluorescence lymphatic imaging (NIRFLI) technology provide opportunities for non-invasive, real-time assessment of lymphatic contribution in the etiology and treatment of ulcers. The objective of this study was to assess lymphatics in subjects with venous leg ulcers using NIRFLI and to assess lymphatic impact of a single session of sequential pneumatic compression (SPC).
Following intradermal microdoses of indocyanine green (ICG) as a lymphatic contrast agent, NIRFLI was used in a pilot study to image the lymphatics of 12 subjects with active venous leg ulcers (Clinical, Etiologic, Anatomic, and Pathophysiologic [CEAP] C6). The lymphatics were imaged before and after a single session of SPC to assess impact on lymphatic function.
Baseline imaging showed impaired lymphatic function and bilateral dermal backflow in all subjects with chronic venous insufficiency, even those without ulcer formation in the contralateral limb (C0 and C4 disease). SPC therapy caused proximal movement of ICG away from the active wound in 9 of 12 subjects, as indicated by newly recruited functional lymphatic vessels, emptying of distal lymphatic vessels, or proximal movement of extravascular fluid. Subjects with the longest duration of active ulcers had few visible lymphatic vessels, and proximal movement of ICG was not detected after SPC therapy.
This study provides visible confirmation of lymphatic dysfunction at an early stage in the etiology of venous ulcer formation and demonstrates the potential therapeutic mechanism of SPC therapy in removing excess fluid. The ability of SPC therapy to restore fluid balance through proximal movement of lymph and interstitial fluid may explain its value in hastening venous ulcer healing. Anatomical differences between the lymphatics of longstanding and more recent venous ulcers may have important therapeutic implications.
近红外荧光淋巴成像(NIRFLI)技术的最新进展为无创、实时评估淋巴系统在溃疡病因及治疗中的作用提供了机会。本研究的目的是使用NIRFLI评估下肢静脉溃疡患者的淋巴管,并评估单次序贯气压治疗(SPC)对淋巴系统的影响。
在皮内微剂量注射吲哚菁绿(ICG)作为淋巴造影剂后,在一项初步研究中使用NIRFLI对12例活动期下肢静脉溃疡患者(临床、病因、解剖和病理生理[CEAP] C6级)的淋巴管进行成像。在单次SPC治疗前后对淋巴管进行成像,以评估对淋巴功能的影响。
基线成像显示,所有慢性静脉功能不全患者,即使对侧肢体无溃疡形成(C0和C4期疾病),其淋巴功能均受损,且存在双侧真皮反流。SPC治疗使12例患者中的9例ICG从活动伤口向近端移动,表现为新募集的功能性淋巴管、远端淋巴管排空或血管外液向近端移动。活动性溃疡持续时间最长的患者可见淋巴管较少,SPC治疗后未检测到ICG向近端移动。
本研究为静脉溃疡形成病因早期的淋巴功能障碍提供了直观证据,并证明了SPC治疗在清除过多液体方面的潜在治疗机制。SPC治疗通过使淋巴和组织间液向近端移动来恢复液体平衡的能力,可能解释了其在加速静脉溃疡愈合方面的价值。长期和近期静脉溃疡淋巴管的解剖差异可能具有重要的治疗意义。